Issue 18, 2001
From the journal:

Chemical Communications

Dodeca(carboranyl)-substituted closomers: toward unimolecular

Jason Thomasa  and  M. Frederick Hawthorne*a  

* Corresponding authors

a Department of Chemistry and Biochemistry, University of California at Los Angeles, Los Angeles, CA, USA.
E-mail: mfh@chem.ucla.edu

Abstract

The syntheses of the dodeca(carboranyl)-substituted closomers, dodeca[7-(2-methyl-1,2-dicarba-closo-dodecaboran-1-yl)heptanoate] -closo-dodecaborate(2−) and dodeca[7-(8-methyl-7,8-dicarba-nido-dodecaboran-7-yl)heptanoate]- closo-dodecaborate(14−) are reported. These boron-rich, unimolecular nanospheres possess great potential for future use as drug-delivery platforms for boron neutron capture therapy (BNCT).

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/B105716M
Article type
Communication
Submitted
28 Jun 2001
Accepted
14 Aug 2001
First published
04 Sep 2001

Chem. Commun., 2001, 1884-1885

Permissions

Request permissions

Dodeca(carboranyl)-substituted closomers: toward unimolecular nanoparticles as delivery vehicles for BNCT

J. Thomas and M. F. Hawthorne, Chem. Commun., 2001, 1884 DOI: 10.1039/B105716M

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements